Ulrich, Sarah
Arnold, Leonie
Michel, Sebastian
Tengler, Anja
Rosenthal, Laura
Hausleiter, Jörg
Mueller, Christoph S.
Schnabel, Brigitte
Stark, Konstantin
Rizas, Konstantinos
Grabmaier, Ulrich
Mehilli, Julinda
Jakob, Andre
Fischer, Marcus
Birnbaum, Julia
Hagl, Christian
Massberg, Steffen
Haas, Nikolaus
Pozza, Robert Dalla
Orban, Madeleine
Funding for this research was provided by:
Novartis Pharma
Klinikum der Universität München
Article History
Received: 27 December 2023
Accepted: 11 June 2024
First Online: 24 June 2024
Declarations
:
: Dr. S. Ulrich used retrospectively some OCT data that had also been previously used in a study supported by Novartis Pharma GmbH. Novartis Pharma GmbH was not involved in the development, realization, and data analysis of this study. Dr. S. Ulrich has also received financial research support from Astellas Pharma GmbH, “Verein zur Förderung von Wissenschaft und Forschung “ (medical faculty of Ludwig-Maximilians-University Munich, Germany) and currently receives financial research support from Gerd-Killian Projektförderung (DGPK, “Deutsche Herzstiftung”, Germany). Dr. Hausleiter reports grants and personal fees from Abbott Vascular and grants and personal fees from Edwards Lifesciences, outside the submitted work. Dr. Mehilli received funding from the German Centre for Cardiovascular Research (DZHK) for material costs of optical coherence tomography and image analysis. Dr. Mehilli reports lecture fees from Daiichi Sankyo, SIS Medical, Biotronik, Astra Zeneca, and Bristol Myers Squibb, outside the submitted work. Dr. Massberg reports grants from the German Federal Ministry of Education and Research (BMBF) / German Center for Cardiovascular Research (DZHK), grants from the German Research Foundation (DFG), grants from Boston Scientific, and grants from Foundation Leduq Transatlantic Network of Excellence, outside the submitted work. The other authors declare no conflicts of interest.